دورية أكاديمية
Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus
| العنوان: | Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus |
|---|---|
| المؤلفون: | Madsen, Michael Moesmann, Kærsvang, Lone, Hansen, Anders Würgler, Flink, Morten, Nielsen, Henning K, Hansen, Klavs Würgler |
| المصدر: | Madsen , M M , Kærsvang , L , Hansen , A W , Flink , M , Nielsen , H K & Hansen , K W 2018 , ' Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus ' , Danish Medical Journal , vol. 65 , no. 9 , A5501 . < http://ugeskriftet.dk/dmj/optimisation-quality-indicators-lipid-lowering-treatment-type-2-diabetes-mellitusTest > |
| سنة النشر: | 2018 |
| المجموعة: | Aarhus University: Research |
| الوصف: | INTRODUCTION: The Danish Adult Diabetes Database (DADD) annually reports a quality indicator for lipid-lowering treatment of type 2 diabetes mellitus (T2DM) patients. This retrospective cohort study aims to A) investigate the reasons for inadequate or lacking lipid-lowering treatment and to B) assess the validity of the DADD indicator as a measure of quality of care. METHODS: A) A pop-up questionnaire enquiring about reasons for lack of treatment was added to the clinicians' data entry tool in the Central Denmark Region. B) The DADD indicator was compared on a per-clinic basis with the achieved median low-density lipoprotein (LDL) cholesterol level and with an internationally widely used indicator of lipid-lowering treatment quality. RESULTS: A) A total of 3,491 patients were registered from 1 January 2013 to 28 February 2015. For 170 (62%) of 309 patients with an LDL level > 2.5 mmol/l who were not receiving lipid-lowering treatment, there was no "good" explanation for lacking treatment. Among 518 patients with an LDL level > 2.5 mmol/l despite lipid-lowering treatment, 259 (50%) did not receive high-intensity treatment. B) The DADD quality indicator was neither associated with the international quality indicator nor with the median per-clinic LDL level for T2DM patients. CONCLUSIONS: A) We found substantial potential for improvement of lipid management among T2DM patients in Denmark by initiating and/or intensifying lipid-lowering treatment. B) The current DADD indicator is not a valid measure of lipid-lowering quality of care. FUNDING: supported by the Rosa and Asta Jensen Foundation. TRIAL REGISTRATION: not relevant. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| الإتاحة: | https://pure.au.dk/portal/da/publications/optimisation-of-quality-indicators-for-lipidlowering-treatment-of-type-2-diabetes-mellitusTest(910d0270-8d56-412c-bfe6-e0792fd63eff).html http://www.scopus.com/inward/record.url?scp=85059797907&partnerID=8YFLogxKTest http://ugeskriftet.dk/dmj/optimisation-quality-indicators-lipid-lowering-treatment-type-2-diabetes-mellitusTest |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.1506E223 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |